These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human Dental Pulp Stem Cells (DPSCs) Therapy in Rescuing Photoreceptors and Establishing a Sodium Iodate-Induced Retinal Degeneration Rat Model. Lam C; Alsaeedi HA; Koh AE; Harun MHN; Hwei ANM; Mok PL; Luu CD; Yong TK; Subbiah SK; Bastion MC Tissue Eng Regen Med; 2021 Feb; 18(1):143-154. PubMed ID: 33415670 [TBL] [Abstract][Full Text] [Related]
3. Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability. March KL; Pepine CJ Circ Res; 2017 Oct; 121(10):1116-1118. PubMed ID: 29074527 [No Abstract] [Full Text] [Related]
4. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160 [TBL] [Abstract][Full Text] [Related]
5. Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy? Traverse JH Circ Res; 2017 Jan; 120(2):256-258. PubMed ID: 28104762 [No Abstract] [Full Text] [Related]
6. Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance. Vrtovec B; Sever M; Jensterle M; Poglajen G; Janez A; Kravos N; Zemljic G; Cukjati M; Cernelc P; Haddad F; Wu JC; Jorde UP Stem Cells Transl Med; 2016 May; 5(5):632-8. PubMed ID: 27025690 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. Butler J; Epstein SE; Greene SJ; Quyyumi AA; Sikora S; Kim RJ; Anderson AS; Wilcox JE; Tankovich NI; Lipinski MJ; Ko YA; Margulies KB; Cole RT; Skopicki HA; Gheorghiade M Circ Res; 2017 Jan; 120(2):332-340. PubMed ID: 27856497 [TBL] [Abstract][Full Text] [Related]
11. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial. Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208 [TBL] [Abstract][Full Text] [Related]
12. Effect of low oxygen tension on the biological characteristics of human bone marrow mesenchymal stem cells. Kim DS; Ko YJ; Lee MW; Park HJ; Park YJ; Kim DI; Sung KW; Koo HH; Yoo KH Cell Stress Chaperones; 2016 Nov; 21(6):1089-1099. PubMed ID: 27565660 [TBL] [Abstract][Full Text] [Related]
13. Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy. Tokita Y; Tang XL; Li Q; Wysoczynski M; Hong KU; Nakamura S; Wu WJ; Xie W; Li D; Hunt G; Ou Q; Stowers H; Bolli R Circ Res; 2016 Aug; 119(5):635-51. PubMed ID: 27364016 [TBL] [Abstract][Full Text] [Related]